A

allafrica.com

@allafrica Mon, 02 Feb 2026 03:10:14

Magoola's Dei Biopharma Develops Scalable Gene-Editing Tool for Sickle Cell Disease

[Nile Post] The U.S. Patent and Trademark Office has accepted a groundbreaking patent from Dei BioPharma Ltd., marking a significant milestone in the treatment of sickle cell disease.

read more

Other Headlines